Literature DB >> 7654196

Effects of calcium on phosphatidylserine- and saposin C-stimulated glucosylceramide beta-glucosidase activity.

E M Prence1.   

Abstract

Glucosylceramide beta-glucosidase is a membrane-bound lysosomal hydrolase that is activated by acidic lipids, the most effective of which is phosphatidylserine (PtdSer), and an activator protein, saposin C. This report documents effects of Ca2+ ions on PtdSer- and saposin C-enhanced beta-glucosidase activity. Ca2+ either increased or decreased enzyme activity, depending on (1) the concentration of phospholipid, and (2) the presence or absence of saposin C. At PtdSer concentrations between 7.6 and 76 microM, in the absence of saposin C, Ca2+ caused an increase in beta-glucosidase activity up to 3 times that measured with PtdSer alone; this was due to both an increase in Vmax, and a decrease in Km. In contrast, at PtdSer concentrations greater than 100 microM, Ca2+ inhibited beta-glucosidase activity by 50%, due to a 2-fold increase in Km. Ca2+ was inhibitory at all PtdSer concentrations tested when both PtdSer and saposin C were present in the assay. Ca2+ ions were also shown to cause changes in the aggregation states of PtdSer. These results suggest that changes in Ca2+ concentration may play a role in regulating beta-glucosidase activity in vivo, thereby modulating sphingolipid metabolism. The implications of these findings are discussed.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7654196      PMCID: PMC1135933          DOI: 10.1042/bj3100571

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  25 in total

1.  Studies on membrane fusion. III. The role of calcium-induced phase changes.

Authors:  D Papahadjopoulos; W J Vail; C Newton; S Nir; K Jacobson; G Poste; R Lazo
Journal:  Biochim Biophys Acta       Date:  1977-03-17

2.  The thyroxine-binding protein of bovine synovial fluid.

Authors:  O W NEUHAUS; V SOGOIAN
Journal:  J Biol Chem       Date:  1959-04       Impact factor: 5.157

3.  Solubilization of glucocerebrosidase from human placenta and demonstration of a phospholipid requirement for its catalytic activity.

Authors:  G L Dale; D G Villacorte; E Beutler
Journal:  Biochem Biophys Res Commun       Date:  1976-08-23       Impact factor: 3.575

Review 4.  Membrane and lipid involvement in blood coagulation.

Authors:  R F Zwaal
Journal:  Biochim Biophys Acta       Date:  1978-07-31

5.  Gaucher's disease: deficiency of 'acid' -glucosidase and reconstitution of enzyme activity in vitro.

Authors:  M W Ho; J S O'Brien
Journal:  Proc Natl Acad Sci U S A       Date:  1971-11       Impact factor: 11.205

6.  beta-Glucosidase activator protein from bovine spleen ("coglucosidase").

Authors:  B L Berent; N S Radin
Journal:  Arch Biochem Biophys       Date:  1981-04-15       Impact factor: 4.013

7.  Statistical analysis of enzyme kinetic data.

Authors:  W W Cleland
Journal:  Methods Enzymol       Date:  1979       Impact factor: 1.600

8.  Purification and properties of a heat-stable glucocerebrosidase activating factor from control and Gaucher spleen.

Authors:  S P Peters; P Coyle; C J Coffee; R H Glew
Journal:  J Biol Chem       Date:  1977-01-25       Impact factor: 5.157

9.  Enzyme replacement therapy in Gaucher's disease: large-scale purification of glucocerebrosidase suitable for human administration.

Authors:  F S Furbish; H E Blair; J Shiloach; P G Pentchev; R O Brady
Journal:  Proc Natl Acad Sci U S A       Date:  1977-08       Impact factor: 11.205

10.  A revised fluorometric assay for Gaucher's disease using conduritol-beta-epoxide with liver as the source of Beta-glucosidase.

Authors:  L B Daniels; R H Glew; N S Radin; R R Vunnam
Journal:  Clin Chim Acta       Date:  1980-09-25       Impact factor: 3.786

View more
  1 in total

1.  Calcium-independent activation of endothelial nitric oxide synthase by ceramide.

Authors:  J Igarashi; H S Thatte; P Prabhakar; D E Golan; T Michel
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-26       Impact factor: 11.205

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.